In this Biotech NOW article, ZS leaders Ed Schoonveld and Juan Roman discuss how pharmaceutical industry thinking has evolved to the new approach of "Managed Entry Agreements" (MEA).
> Download ( /-/media/files/publications/public/biotechnow-managed-entry-trumps-risk-sharing-final.pdf?la=en )